1 suspended, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 1, Terminated 1 |
| Phase 3 | 2 | Suspended 1, Terminated 1 |
Follow Severe Pneumonia: new trials by email Literature Review of Severe Pneumonia trials Research Report on Severe Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 Yinhu Qingwen Granula, Yin Hu Qing Wen Granula(low does), standard medical treatment - COVID-19, Severe Pneumonia | Phase 2 / Phase 3 | Suspended | Zhong Wang | 116 | 2021-11-01 | 2021-07-07 |
| Reparixin in COVID-19 Pneumonia - Efficacy and Safety Reparixin, Standard of care - Severe Pneumonia | Phase 2 / Phase 3 | Terminated | Dompé Farmaceutici S.p.A | 56 | 2020-05-05 | 2024-01-08 |
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2)
Standard of Care (1) · reparixin (1)
Dompé Farmaceutici S.p.A (1) · Zhong Wang (1)
Brazil (1) · China (1) · Italy (1)
Alberto Zangrillo, MD PhD (1) · Dong Shang, M.D. (1) · Jiang-Rong Huang, M.D. (1) · Lorenzo Piemonti, MD PhD (1) · Xiao-Dong Li, M.D. (1) · Zhong Wang, M.D. (1)